(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2...ady option that can work like a magic potion to co...sode of stroke or cerebro// vascular accident(CVA)...University ,who conducted a study on mice, reveal... found commonly in the skin of red grapes, adminis...
...t overweight youngsters lose weight by concentrati...d are likely to make them// gorge even more, accor...y are no more motivated to change their eating hab...y with their appearance. Rather the researchers ...
...tudy conducted by epidemiologists of Dupont & Co.,...rtality risk among the workers at// DuPont who ar... the key component of the material Teflon. The st...ompany definitely reveals lower mortality rates t...
...kungunya fever in Kerala will not affect the state...iyeri Balakrishnan said Tuesday. "As the World He... saying that the fever widespread here is not chik... have been no reports of cancellation by tourists ...
Other Medicine News:Health News:Obese Kids Unmotivated byWeight Loss campaigns 2(Date:9/4/2008)...RNewswire-FirstCall/ -- BioForm Medical,Inc. (Nas...ical study of,Polidocanol, conducted in Germany by...SLER & Co. GmbH (Kreussler), successfully met the ...DA as part of a New Drug Application,(NDA) process...(Efficacy and safety of,Aethoxysklerol compared to...
(Date:9/4/2008)...0 Women at More Than 100 Sites in the U.S., ANN A...ceuticals, a,privately-held biopharmaceutical comp...f compounds to treat endocrine, metabolic and,card...initiated a second,Phase 3 clinical trial of Ophen...-free oral therapy in development for the treatmen...
(Date:9/4/2008)...chedule with Two Abstracts Accepted for Presen...r 2008, BRIDGEWATER, N.J., Sept. 4 /...maceutical company focused on the treatment of,car... the appointment of,Peter L. Garrambone, Jr. to th...,s career includes more than 50 pharmaceutical,tra...
(Date:9/3/2008)... from chronically infected Hepatitis C,patients st...arlier in 2008, - Study is the first to show a s...viral effect of therapeutic Hepatitis C vaccinatio... into a second generation, vaccine formulated wit... activation, VIENNA,...
Breaking Medicine Technology:338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 2338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 4338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 5QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 2QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 3Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 3Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 4Millennium Biotechnologies Group Inc 28MBTG OB 29 Announces Appointment of Mark C Mirken as its President and Chief Operating Officer 525 1Millennium Biotechnologies Group Inc 28MBTG OB 29 Announces Appointment of Mark C Mirken as its President and Chief Operating Officer 525 2Millennium Biotechnologies Group Inc 28MBTG OB 29 Announces Appointment of Mark C Mirken as its President and Chief Operating Officer 525 3Tamoxifen Helps Treat Bipolar Disorder 1086 1Tamoxifen Helps Treat Bipolar Disorder 1086 2Tamoxifen Helps Treat Bipolar Disorder 1086 3Putting stem cell research on the fast track 359 1Putting stem cell research on the fast track 359 2Putting stem cell research on the fast track 359 3Putting stem cell research on the fast track 359 4Ken Sperling to Lead CIGNA HealthCare Retiree Solutions Unit 1079 1Ken Sperling to Lead CIGNA HealthCare Retiree Solutions Unit 1079 2...ESS WIRE)--Apr 12, 2007 - Affymax, Inc.,(Nasdaq:AF...s Phase,2 clinical trial of Hematide(TM) dosed mon... at the National Kidney Foundation (NKF),2007 Spri...ance-switch trial in patients previously treated w...ated that mean,hemoglobin (Hgb) levels can be main...
...The costs of eradicating,poliomyelitis from the re...t term, are much lower than the long term costs of... And a recently developed,monovalent vaccine is al...iomyelitis than an existing trivalent vaccine. The...ne and in an upcoming,issue of The Lancet. , Both ...
Other Medicine Technology:Affymax Announces Results From Phase 2 Clinical Trial of Hematide,for the Treatment of Anemia in Dialysis Patients 2Affymax Announces Results From Phase 2 Clinical Trial of Hematide,for the Treatment of Anemia in Dialysis Patients 3Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 2Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 3Rhoton Curettes, titanium, length 191 mm, straight.
Castroviejo "HM" Micro Needle Holder with Tungsten-Carbide Inserts, with catch. Serrated.
Clinical micro clamps by Acland. Matte finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface.
Clinical micro clamps by Acland. Matte finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface.
Medicine Products: